Suppr超能文献

腹腔镜与经皮射频消融治疗肾肿块的安全性、肾功能结局和疗效比较。

Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses.

机构信息

Department of Urology, Division of Endourology, Laparoscopy, and Minimally Invasive Surgery, University of Miami, Miller School of Medicine, Miami, Florida.

出版信息

J Urol. 2012 Apr;187(4):1177-82. doi: 10.1016/j.juro.2011.11.099. Epub 2012 Feb 20.

Abstract

PURPOSE

With the increased incidence of low stage renal cancers, thermal ablation technology has emerged as a viable treatment option. Current AUA (American Urological Association) guidelines include thermal ablation as a treatment modality for select individuals. We compared the laparoscopic and percutaneous approach for the radio frequency ablation of renal tumors under the guidance of urological surgeons.

MATERIALS AND METHODS

We reviewed our radio frequency ablation database of patients with renal masses undergoing laparoscopic or computerized tomography guided percutaneous radio frequency ablation with simultaneous peripheral fiberoptic thermometry from November 2001 to January 2011 at a single tertiary care center. Data were collected on patient demographics, and surgical and clinicopathological outcomes stratified by approach.

RESULTS

A total of 298 patients with 316 renal tumors underwent laparoscopic (122 tumors) or computerized tomography guided (194 tumors) radio frequency ablation. There were no statistically significant differences between the laparoscopic and computerized tomography guided radio frequency ablation groups with respect to patient demographics, complication rates and renal functional outcomes (p>0.05). The 3-year Kaplan-Meier estimation of radiographic recurrence-free probability was 95% for computerized tomography guided radio frequency ablation and 94% for laparoscopic radio frequency ablation (p=0.84). Subanalysis of the 212 (67%) renal cell carcinoma tumors showed a 3-year Kaplan-Meier estimation of oncologic recurrence-free probability (post-ablation biopsy proven viable tumor) of 94% for computerized tomography guided radio frequency ablation and 100% for laparoscopic radio frequency ablation (p=0.16). Median followup was 21 months for laparoscopic radio frequency ablation) and 19 months for computerized tomography guided radio frequency ablation.

CONCLUSIONS

Laparoscopic and computerized tomography guided radio frequency ablation appear safe and effective with statistically equivalent rates of complications and recurrence.

摘要

目的

随着低分期肾癌发病率的增加,热消融技术已成为一种可行的治疗选择。目前,美国泌尿外科学会(AUA)指南将热消融作为一种治疗选择纳入其中,适用于特定人群。我们比较了腹腔镜和经皮途径在泌尿外科医生指导下对肾肿瘤进行射频消融的效果。

材料和方法

我们回顾了 2001 年 11 月至 2011 年 1 月在一家三级医疗中心接受腹腔镜或计算机断层扫描引导经皮射频消融并同时进行外周光纤测温的肾肿块患者的射频消融数据库。收集了患者人口统计学、手术和临床病理结果的数据,并按治疗途径进行分层。

结果

共有 298 例 316 个肾肿瘤患者接受了腹腔镜(122 个肿瘤)或计算机断层扫描引导(194 个肿瘤)射频消融。腹腔镜和计算机断层扫描引导射频消融组在患者人口统计学、并发症发生率和肾功能结果方面无统计学差异(p>0.05)。计算机断层扫描引导射频消融的 3 年无影像学复发率的 Kaplan-Meier 估计为 95%,腹腔镜射频消融为 94%(p=0.84)。对 212 例(67%)肾细胞癌肿瘤的亚分析显示,计算机断层扫描引导射频消融的 3 年无肿瘤学复发率(消融后活检证实为活肿瘤)的 Kaplan-Meier 估计为 94%,腹腔镜射频消融为 100%(p=0.16)。腹腔镜射频消融的中位随访时间为 21 个月,计算机断层扫描引导射频消融为 19 个月。

结论

腹腔镜和计算机断层扫描引导射频消融似乎是安全有效的,并发症和复发的发生率统计学上无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验